DecisionHealth, DecisionHealth - 2010 Issue 5 (May)
Benchmark of the Week: Price shifts for top 10 oncology drugs
Reimbursement for seven of the 10 top oncology drugs billed to Medicare have increased over the last three years under CMS's average sales price (ASP) lists, a Part B News analysis shows. However, the overall positive trend for most of these codes hasn't been consistent. NOTE: These codes were selected based on their overall utilization and on how frequently they were billed by a high-volume oncology practice in California. Remember: The 2010 pricing is based on the latest Q2 ASP list from CMS.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.
Thank you for choosing Find-A-Code, please Sign In to remove ads.